Genetic testing plays a vital role in diagnosing and treating hematologic malignancies. It enables precise disease classification, prognostic stratification, and personalized treatment planning, guiding targeted therapies and minimizing adverse reactions. By detecting gene mutations and monitoring minimal residual disease (MRD), it helps assess relapse risks and improve patient outcomes.

Many patients wonder: How long can CAR-T therapy last? Its long-term efficacy depends not only on the initial anti-tumor effect but also on the persistence of CAR-T cells in the body. Factors like T-cell quality, production process, tumor immune escape, and standardized whole-process management all affect outcomes. To improve durability, doctors recommend early intervention, optimized cell preparation, personalized targets, and long-term monitoring.

A major new medical policy has arrived! Personalized mRNA cancer vaccines are now available for 6 types of digestive system tumors, including pancreatic, liver, gastric, and colorectal cancer. This tailored vaccine trains your immune system to target residual cancer cells, greatly lowering recurrence risk and extending survival. Important: eligibility must be confirmed BEFORE surgery, as fresh tumor tissue is required for vaccine development. Don’t miss this life-changing opp